Norchlorcyclizine (CAS No: 303-26-4) is a key pharmaceutical intermediate used in the synthesis of APIs Buclizine, Cetirizine, Etodroxizine, Hydroxyzine, Levocetirizine, Levocetirizine dihydrochloride and Meclizine. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: N-(p-Chlorobenzhydryl)piperazine, 4-(4-Chlorobenzhydryl)piperazine
CAS No: 303-26-4
PubChem CID: 9340
Mol Formula: C17H19ClN2
Mol Weight: 286.8 g/mol
Used in APIs: Buclizine, Cetirizine, Etodroxizine, Hydroxyzine, Levocetirizine, Levocetirizine dihydrochloride and Meclizine
IUPAC Name: 1-[(4-chlorophenyl)-phenylmethyl]piperazine
API Intermediate Description: Norchlorcyclizine is a metabolite of the first-generation antihistamine chlorcyclizine and shares its uses, primarily for treating allergy symptoms like rhinitis and urticaria, as well as motion sickness and vertigo. It has antihistaminic, antiemetic (anti-nausea), anticholinergic, and local anesthetic properties.
